Certified by Founder Lodge
Abcuro, Inc

START UP
1 Disclosed Funding Rounds $155,000,000
0 Participating Investments
-
Founded date
2015
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Abcuro is a clinical stage biotechnology company developing treatments for autoimmune and cancer indications modulated by cytotoxic T and NK cells that express the inhibitory immune checkpoin
Date | Round | Raised | Participating Investors |
---|---|---|---|
August, 18 ,2023 | Series B | $155,000,000 |